SCIENTISTS from the Keele
University in the UK are set to
commence a year-long trial of stem
cell therapy for osteoarthritis.
Seventy participants with
osteoarthritis of the knee
will take place in the trial which will
see them undergo keyhole surgery
to remove cartilage cells and bone
marrow stem cells.
The removed cells will then be
grown in a lab for three weeks
before being reimplanted into
patients legs, either separately, or in
some patients mixed together.
The aim of the trial is to gauge
whether combining cartilage cells
with bone marrow stem cells is
more effective than the current
procedure of reinjecting just
cartilage cells into damaged knees.
Results of the trial will be based
on the quality of patient cartilage
formed over a period of 12
months.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Sep 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Sep 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.